FDA Will Pull Vet Drug Used in Pork Industry Over Cancer Concerns for Humans

Follow Drugslib on

Medically reviewed by Drugs.com.

By Robin Foster HealthDay Reporter

WEDNESDAY, Nov. 8, 2023 (Healthday News) -- The U.S. Food and Drug Administration said Tuesday that it plans to pull a veterinary drug used commonly in the pork industry because it might pose a cancer risk to humans who eat pig products.

The antimicrobial, carbadox (Mecadox), is typically added to pig feed to fight infections and fatten up the animals.

But pork contaminated with "carcinogenic residues" from the drug could wind up in foods like hot dogs and cold cuts, though the agency stressed in its notice that it isn't telling people to change their food choices at the moment.

The FDA's concerns with carbadox date back decades: When it was first approved in 1998, the agency's worries were abated by a strategy that involved testing edible parts of pigs that had been given carbadox. According to the agency, data now shows that those testing methods do not adequately measure the cancer risk posed by pork produced while using the drug.

After issuing its first warning about pulling the drug in 2016, it isn't clear why the agency didn't move sooner to actually do so, CBS News reported.

"This action itself arrived long overdue. The European Union and Canada prohibited use of carbadox in 1999 and 2006, respectively, due to concerns about residues and the safety of workers handling the drug," advocacy groups wrote in a 2022 letter to the agency.

"Because the FDA first made public its concern regarding the adequacy of the 1998-approved [testing] method with regard to carbadox in 2016, the swine industry has had the opportunity to consider and mitigate potential impacts of this action for several years," the agency said in a post about the drug.

Drug maker Phibro Animal Health Corp. said Tuesday it was "extremely disappointed" by the FDA's latest move.

"While Phibro has continuously offered to meet with FDA to discuss the regulatory method and has offered viable alternative methods currently being used in other countries, it is clear that, instead, the FDA is ignoring the long history of safety that Phibro has established and reaffirmed through its most recent studies," the company said in a news release.

Pulling carbadox from the market could also result in millions of lost pigs, the National Pork Producers Council claimed.

"It is a vital product to treat gastrointestinal disease [swine dysentery] in young pigs, improving their health and welfare. With few interventions available, carbadox is essential," the council told CBS News.

Phibro could have one more chance to persuade the FDA not to pull its carbadox approvals.

The drugmaker could submit a request for a hearing to the agency raising "a genuine and substantial issue of fact." The deadline for such a request is Dec. 7, the FDA's notice said.

"Phibro will take appropriate action and next steps to continue to defend swine producers' ability to use Mecadox to protect the health and welfare of their animals," the company said.

Sources

  • CBS News

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2023-11-08 21:08

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords